IL1B and cancer: The SOD activity in erythrocytes was positively correlated with cancer stage (ρ = 0.34, p = 0.012) and inflammatory mediators IL-1β (r = 0.38, p = 0.006) and TNFα (r = 0.42, p = 0.002) but was not associated with patient-related features.